Assessment of Zika Prevention Strategies in the U.S. Virgin Islands

ICR 201611-0920-001

OMB: 0920-1147

Federal Form Document

Forms and Documents
Document
Name
Status
Form and Instruction
New
Form and Instruction
New
Supporting Statement A
2016-11-16
Supporting Statement B
2016-11-09
Supplementary Document
2016-11-09
Supplementary Document
2016-11-09
Supplementary Document
2016-11-07
Supplementary Document
2016-11-01
ICR Details
0920-1147 201611-0920-001
Historical Active
HHS/CDC 17CR
Assessment of Zika Prevention Strategies in the U.S. Virgin Islands
New collection (Request for a new OMB Control Number)   No
Emergency 11/17/2016
Approved with change 11/16/2016
Retrieve Notice of Action (NOA) 11/16/2016
Approved consistent with the understanding that this clearance grants 3 months of data collection. The program will publish 60 and 30 day Federal Register notices and submit a standard ICR for regular OMB review/approval as soon as it is anticipated that the collection may extend beyond the 3 month clearance.
  Inventory as of this Action Requested Previously Approved
02/28/2017 3 Months From Approved
425 0 0
121 0 0
0 0 0

The overarching goal of this project is to engage key audiences in the U.S. Virgin Islands (USVI) regarding a variety of Zika prevention activities (personal protective behaviors and vector control activities) in order to assess the current situation and to inform future action. Information collected in this assessment will be used to help refine communication and vector control plans and guide implementation of activities defined in those plans in order to prevent and control Zika virus in the U.S. Virgin Islands.
Recently, the U.S. Virgin Islands has seen a large jump in cases. Response leaders at the U.S. Virgin Islands Department of Health and CDC have asked the behavioral science team to do a comprehensive assessment of different facets of the response among several audiences in order to help understand the current situation and to inform next steps. The U.S. Virgin Islands has reported 1,425 cases of Zika with 575 laboratory-confirmed cases. Sixty-one of these cases are among pregnant women. Because Zika is an emerging arboviral disease and a sexually transmitted disease that is known to cause microcephaly and other serious birth defects in babies if a pregnant woman is infected during her pregnancy, an urgent assessment of individuals’ Zika prevention strategies is urgently needed to inform the ongoing response in the U.S. Virgin Islands.

US Code: 42 USC 241 Name of Law: U.S. Public Health Service Act
  
None

Not associated with rulemaking

No

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 425 0 0 425 0 0
Annual Time Burden (Hours) 121 0 0 121 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
Submission of 0920-17CR is a New Emergency ICR related to the Zika Virus response.

$156,062
Yes Part B of Supporting Statement
No
No
No
No
Uncollected
Jeffrey Zirger 404 639-7118 wtj5@cdc.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
11/16/2016


© 2024 OMB.report | Privacy Policy